Command Palette

Search for a command to run...

ADVENZYMES
310.9(+1.44%)
1W: -5.89%

Advanced Enzyme Technologies Peer Comparison

Snapshot Summary

Advanced Enzyme Technologies Ltd. demonstrates solid growth metrics and profitability compared to its peers, but has a relatively high PE ratio. While it shows good revenue growth, its valuation metrics suggest it may not be the most attractive investment compared to others in the sector. Companies like Dr. Reddy's Laboratories and Cipla present stronger overall financial profiles, suggesting they could be better investment choices.

  • Advanced Enzyme Technologies Ltd. shows strong revenue growth (YoY) of 15.39% but has a high PE ratio of 37.00.
  • Dr. Reddy's Laboratories Ltd. and Cipla Ltd. display better profitability and valuation metrics, making them strong contenders in the sector.
  • Companies like Divi's Laboratories and Sun Pharmaceutical appear overvalued based on their profitability metrics.
  • Dr. Reddy's Laboratories Ltd.: Highest ROE (21.76%) and solid growth metrics, making it a top performer.
  • Cipla Ltd.: Strong profitability metrics with a low PE ratio of 23.73, indicating good value.
Stocks
CMP
Market Cap
P/E
ROCE (%)
Debt/Equity
ADVENZYMES₹338.70₹3,789.41Cr37.0014.78%0.02
SUNPHARMA₹1,563.35₹3,75,099.26Cr87.5917.60%0.04
DIVISLAB₹6,091.05₹1,61,698.50Cr73.2016.46%-
CIPLA₹1,587.60₹1,28,217.27Cr23.7322.77%0.01
TORNTPHARM₹3,581.55₹1,21,215.77Cr61.5324.28%0.57
DRREDDY₹1,280.30₹1,06,835.27Cr15.5026.86%0.07
MANKIND₹2,518.95₹1,03,926.59Cr55.1828.38%0.02

Leveling the playing field in markets.

© 2025 EQHQ Technologies Pvt Ltd

"Information provided is for educational purposes only and not financial advice.